Blood glucose related adverse drug reaction of antitumor monoclonal antibodies: a retrospective analysis using Vigibase. (2023). Brazilian Journal of Pharmaceutical Sciences, 59, e18893. https://doi.org/10.1590/s2175-97902020000118893